# Virtual Cell Analysis Report

**Perturbation:** KO TP53
**Cell Type:** HepG2
**Species:** human
**Date:** 2025-11-15 18:44:18

## Query
What happens if I knock out TP53 in HepG2 cells?

## Methods

This analysis was performed using the Virtual Cell system, which integrates:
- **Differential Expression Analysis:** RNA-seq data analysis
- **Pathway Enrichment:** GSEA (Gene Set Enrichment Analysis) and PSEA (Pathway Set Enrichment Analysis)
- **Phenotype Layer:** Unified phenotype knowledge base integrating G2P, HPO, CTD, DisGeNET, and CellMarker
- **Literature Integration:** Edison Scientific RAG system (PaperQA) for evidence retrieval
- **Hypothesis Generation:** Mechanistic hypothesis generation with literature support

## Key Results

**Pathway Enrichment:** 5 significantly enriched pathways (FDR ≤ 0.05)

Top enriched pathways:
1. p53 signaling pathway (NES=2.50, FDR=0.001)
2. Cell cycle (NES=2.10, FDR=0.003)
3. Apoptosis (NES=-2.30, FDR=0.002)
4. DNA repair (NES=-1.80, FDR=0.010)
5. Cell cycle checkpoints (NES=1.90, FDR=0.008)

![Pathway Enrichment](/home/nebius/cellian/llm/test_output/pathway_enrichment.png)

## Phenotype Predictions

Top predicted phenotypes:

1. **Increased cell proliferation** ↑ (score: 0.82, ID: HP:0000086)
   - Supporting genes: CCND1, PCNA, MYC
2. **Increased apoptosis** ↑ (score: 0.75, ID: HP:0001903)
   - Supporting genes: BAX, CASP3, FAS
3. **Neoplasia** ↑ (score: 0.71, ID: HP:0002664)
   - Supporting genes: TP53, MYC, CCND1, RB1
4. **Abnormal DNA repair** ↓ (score: 0.68, ID: HP:0002814)
   - Supporting genes: ATM, CHEK2, GADD45A, TP53
5. **Cell cycle arrest** ↓ (score: 0.58, ID: HP:0000952)
   - Supporting genes: CDKN1A, P21, RB1

![Phenotype Scores](/home/nebius/cellian/llm/test_output/phenotype_scores.png)

## Mechanistic Hypotheses

Generated 5 testable mechanistic hypotheses:

### Hypothesis H1: KO TP53 increases increased cell proliferation in HepG2 cells

**Mechanism:**
- Perturbation: KO TP53
- Affects genes: CCND1, PCNA, MYC
- Enriches pathway: Cell cycle
- Predicts phenotype: Increased cell proliferation (increase)

**Phenotype Support:** Increased cell proliferation (increase, score=0.82)

**Literature Support:** WEAK
Weak or indirect evidence. Found 3 potentially relevant papers but limited direct support.

**Predicted Experimental Readouts:**
- Cell count (increase)
- Ki-67 staining (immunofluorescence)
- Cell cycle analysis (PI staining + flow cytometry)

**Suggested Experiments:**
- Perform KO TP53 in HepG2 cells and measure increased cell proliferation markers at 24h, 48h, and 72h post-perturbation

**Notes:**
Directly supported by 6 validated regulatory edges. Literature support: 3 relevant papers found.

---

### Hypothesis H2: KO TP53 activates p53 signaling pathway, leading to neoplasia

**Mechanism:**
- Perturbation: KO TP53
- Enriches pathway: p53 signaling pathway (NES=2.50, FDR=0.001)
- Affects pathway genes: TP53, CDKN1A, BAX, MDM2, P21
- Predicts phenotype: Neoplasia

**Phenotype Support:** Neoplasia (increase, score=0.71)

**Literature Support:** WEAK
Weak or indirect evidence. Found 3 potentially relevant papers but limited direct support.

**Predicted Experimental Readouts:**
- RNA-seq transcriptome profiling
- Protein expression (Western blot or mass spectrometry)
- Cell viability assay (MTT or CellTiter-Glo)

**Suggested Experiments:**
- Perform KO TP53 in HepG2 cells and perform pathway activity assay for p53 signaling pathway at 24h

**Notes:**
Directly supported by 6 validated regulatory edges. Literature support: 3 relevant papers found.

---

### Hypothesis H3: KO TP53 inhibits Apoptosis, leading to increased apoptosis

**Mechanism:**
- Perturbation: KO TP53
- Enriches pathway: Apoptosis (NES=-2.30, FDR=0.002)
- Affects pathway genes: BAX, BCL2, CASP3, FAS
- Predicts phenotype: Increased apoptosis

**Phenotype Support:** Increased apoptosis (increase, score=0.75)

**Literature Support:** WEAK
Weak or indirect evidence. Found 3 potentially relevant papers but limited direct support.

**Predicted Experimental Readouts:**
- RNA-seq transcriptome profiling
- Protein expression (Western blot or mass spectrometry)
- Cell viability assay (MTT or CellTiter-Glo)

**Suggested Experiments:**
- Perform KO TP53 in HepG2 cells and perform pathway activity assay for Apoptosis at 24h

**Notes:**
Directly supported by 6 validated regulatory edges. Literature support: 3 relevant papers found.

---

### Hypothesis H4: KO TP53 downregulates CDKN1A via TP53, leading to neoplasia

**Mechanism:**
- Perturbation: KO TP53
- Directly affects TP53 → CDKN1A (down, confidence=0.85)
- Propagates through pathway: p53 signaling pathway
- Predicts phenotype: Neoplasia

**Phenotype Support:** Neoplasia (increase, score=0.71)

**Literature Support:** WEAK
Weak or indirect evidence. Found 3 potentially relevant papers but limited direct support.

**Predicted Experimental Readouts:**
- Expression of CDKN1A (qRT-PCR or RNA-seq)

**Suggested Experiments:**
- Validate TP53 → CDKN1A interaction using ChIP-seq or co-IP

**Notes:**
Directly supported by 1 validated regulatory edges. Literature support: 3 relevant papers found.

---

### Hypothesis H5: KO TP53 downregulates BAX via TP53, leading to increased apoptosis

**Mechanism:**
- Perturbation: KO TP53
- Directly affects TP53 → BAX (down, confidence=0.82)
- Propagates through pathway: p53 signaling pathway
- Predicts phenotype: Increased apoptosis

**Phenotype Support:** Increased apoptosis (increase, score=0.75)

**Literature Support:** WEAK
Weak or indirect evidence. Found 3 potentially relevant papers but limited direct support.

**Predicted Experimental Readouts:**
- Expression of BAX (qRT-PCR or RNA-seq)

**Suggested Experiments:**
- Validate TP53 → BAX interaction using ChIP-seq or co-IP

**Notes:**
Directly supported by 1 validated regulatory edges. Literature support: 3 relevant papers found.

---

## Limitations & Notes

- **Computational Predictions:** This analysis is based on computational predictions and requires experimental validation.
- **Literature Evidence:** Literature support classification is automated and should be manually reviewed for critical hypotheses.
- **Tissue/Cell Context:** Results are specific to the analyzed cell type and may not generalize to other contexts.
- **Dynamic Processes:** This analysis represents a snapshot and does not capture temporal dynamics of cellular responses.

---

*Report generated by Virtual Cell system*
